How effective is a stellate ganglion block for panic attacks in adults?

Stellate Ganglion Block for Panic Attacks: Not Recommended as Standard Treatment

Stellate ganglion block (SGB) should not be used as a standard treatment for panic attacks in adults, as there is no guideline support and insufficient evidence specific to panic disorder. The available evidence focuses primarily on PTSD and generalized anxiety disorder, not panic attacks specifically.

Evidence Analysis

Guideline Recommendations

The most recent anxiety disorder guidelines 1 make no mention of stellate ganglion block for any anxiety disorder, including panic disorder. These 2023 Japanese guidelines specifically recommend:

• SSRIs (weak recommendation, low certainty evidence)
• SNRIs (venlafaxine) (weak recommendation, low certainty evidence)
• Cognitive behavioral therapy (weak recommendation, low certainty evidence)

Research Evidence Limitations

The research evidence has critical gaps for panic attacks:

Wrong Population: The strongest evidence is for PTSD, not panic disorder:

• The 2026 RCT 2 studied treatment-resistant generalized anxiety disorder (GAD), not panic attacks
• The 2025 RCT 3 studied GAD with sleep disturbance, explicitly excluding depression
• Most studies focus on PTSD 4, 5, 6, 7

Panic Disorder vs. Other Anxiety Disorders: While the 2026 RCT 2 showed dual SGB reduced GAD-7 scores by 9.6 points at 4 weeks (vs. 3.6 for sham, p<0.001), and the 2023 case series 8 showed GAD-7 reductions of 9.0 points at 1 week in 285 patients, panic disorder has distinct pathophysiology involving different neural circuits than GAD or PTSD.

Clinical Reasoning

Why SGB Is Not Appropriate for Panic Attacks

1. Different symptom profile: Panic attacks involve acute, episodic sympathetic surges with discrete episodes of terror, whereas the SGB literature focuses on chronic hyperarousal states

2. Mechanism mismatch: SGB targets sustained sympathetic overactivity. Panic disorder involves paroxysmal activation, not sustained baseline elevation

3. No panic-specific outcomes: None of the studies measured panic attack frequency, panic severity scales (PDSS), or agoraphobia—the core outcomes for panic disorder

4. Safety concerns: One case report 7 documented paradoxical worsening of anxiety after left-sided SGB, requiring reversal with right-sided block

Recommended Approach for Panic Attacks

Use evidence-based treatments with guideline support:

1. First-line pharmacotherapy: SSRIs (escitalopram, sertraline, paroxetine) or SNRIs (venlafaxine)
2. First-line psychotherapy: Panic-focused CBT with interoceptive exposure
3. Acute management: Benzodiazepines only for short-term bridging (avoid long-term due to dependence risk)

When to Consider SGB (Not for Panic Attacks)

SGB may have a role in treatment-resistant GAD 2 or PTSD 5, 6 when:

• Multiple medication trials have failed
• CBT has been inadequate
• Predominant symptoms are chronic hyperarousal (not episodic panic)
• Patient is managed by multidisciplinary team including psychiatry

Critical caveat: Even in these conditions, SGB remains investigational and should not replace guideline-concordant care. The procedure requires specialized expertise in ultrasound-guided techniques and carries risks including Horner's syndrome, pneumothorax, and paradoxical anxiety worsening 7.